Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Nobuyuki Shiraga"'
Autor:
Yujiro Aoki, Takeshi Kawamura, Nobuyuki Shiraga, Takashi Yonekura, Maho Maeda, Sota Kurihara, Yoshitaka Sekine, Seiichiro Shishido, Ken Sakai
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-7 (2023)
Abstract Background Arteriovenous fistula (AVF) due to renal allograft biopsy is mechanical trauma resulting from the penetration of small arteries and veins by a core needle. Most AVFs are reported to resolve asymptomatically and spontaneously. This
Externí odkaz:
https://doaj.org/article/4824006d20ec4a34b00017db77a0bc83
Autor:
Satoshi Koezuka, Atsushi Sano, Yoko Azuma, Takashi Sakai, Keiko Matsumoto, Nobuyuki Shiraga, Tetuo Mikami, Naobumi Tochigi, Yoshitaka Murakami, Akira Iyoda
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Lung adenocarcinomas presenting as solid nodules are occasionally diagnosed as lepidic predominant lesions. The aim of this study was to clarify the histological structure and to identify factors predictive of lepidic predominant lesions. We
Externí odkaz:
https://doaj.org/article/5b2e1e6abe73417d8ab823463d559606
Autor:
Shigenori Hiruma, Fumika Shigiyama, Shinji Hisatake, Sunao Mizumura, Nobuyuki Shiraga, Masaaki Hori, Takanori Ikeda, Takahisa Hirose, Naoki Kumashiro
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background While the cardioprotective benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors have been established in patients with cardiovascular disease (CVD), their advantages over other anti-diabetic drugs at earlier stages remain
Externí odkaz:
https://doaj.org/article/34b99b5f900c4db7aaf8536df3e9e7f9
Autor:
Keishi Sugino, Masahiro Kobayashi, Yasuhiko Nakamura, Kyoko Gocho, Fumiaki Ishida, Kazutoshi Isobe, Nobuyuki Shiraga, Sakae Homma
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170289 (2017)
Little has been reported on the feasibility of xenon-enhanced dual-energy computed tomography (Xe-DECT) in the visual and quantitative analysis of combined pulmonary fibrosis and emphysema (CPFE).We compared CPFE with idiopathic pulmonary fibrosis (I
Externí odkaz:
https://doaj.org/article/6660bc1c927e4b6395b2399bc2a7d23a
Publikováno v:
Oxford Medical Case Reports. 2022
Yellow nail syndrome (YNS) is a rare disorder characterized by the triad of yellow nails, lymphedema and chronic respiratory manifestations. Lymphatic abnormalities are a characteristic finding of YNS. Nevertheless, proof of lymphatic vessel abnormal
Autor:
Satoshi Koezuka, Atsushi Sano, Yoko Azuma, Takashi Sakai, Keiko Matsumoto, Nobuyuki Shiraga, Tetuo Mikami, Naobumi Tochigi, Yoshitaka Murakami, Akira Iyoda
Publikováno v:
Scientific reports. 12(1)
Lung adenocarcinomas presenting as solid nodules are occasionally diagnosed as lepidic predominant lesions. The aim of this study was to clarify the histological structure and to identify factors predictive of lepidic predominant lesions. We retrospe
Autor:
Hidenari Nagai, Naoki Kumashiro, Nobuyuki Shiraga, Fumika Shigiyama, Takahisa Hirose, Noritaka Wakui, Hiroyuki Igarashi, Kazutoshi Shibuya
Publikováno v:
Hepatology Research. 49:1374-1385
Aim Current approaches for hepatic steatosis assess only a small point within the liver and might cause inaccuracy for longitudinal observation. We aimed to establish a reliable non-invasive method for whole hepatic lipid content evaluation. Methods
Autor:
Fumika Shigiyama, Shinji Hisatake, Takanori Ikeda, Takahisa Hirose, Shigenori Hiruma, Nobuyuki Shiraga, Naoki Kumashiro
Publikováno v:
Diabetes Therapy
Introduction Ectopic fat accumulation has been found to play a pathophysiological role in insulin resistance, type 2 diabetes (T2DM), and coronary artery diseases. Findings from a number of previous studies suggest that sodium glucose cotransporter 2
Autor:
Takahisa Hirose, Shigenori Hiruma, Nobuyuki Shiraga, Naoki Kumashiro, Masaaki Hori, Takanori Ikeda, Shinji Hisatake, Fumika Shigiyama, Sunao Mizumura
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Background While the cardioprotective benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors have been established in patients with cardiovascular disease (CVD), their advantages over other anti-diabetic drugs at earlier stages remain unclear.
Autor:
Takahisa Hirose, Shigenori Hiruma, Shinji Hisatake, Sunao Mizumura, Takanori Ikeda, Fumika Shigiyama, Masaaki Hori, Nobuyuki Shiraga, Naoki Kumashiro
Publikováno v:
Diabetes. 69
Background: Ectopic fat accumulation is the major pathogenesis of insulin resistance, type 2 diabetes mellitus (T2DM), and cardiovascular diseases. To date, no prospective study compared the effects of sodium glucose cotransporter 2 inhibitors (SGLT2